In addition, as we showed in the clinical course of Pt.7 cells (Fig. 5), ALA-PDT worked regardless of the presence or absence of CCR4 expression on tumor cells, suggesting PDT can work without cross-resistance to CCR4-antibody treatment as well as to chemotherapy. This evidence concerns the gene CCR4 and neoplasm.